These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

100 related items for PubMed ID: 8571742

  • 1. [Detection of minimal residual disease in acute leukemias by immunophenotyping of bone marrow cells].
    Deptała A, Widzyńska I, Kuratowska Z.
    Acta Haematol Pol; 1995; 26(4):403-11. PubMed ID: 8571742
    [Abstract] [Full Text] [Related]

  • 2. [Clinical significance and prognostic detection of minimal residual disease in acute leukemias].
    Deptała A, Widzyńska I, Kuratowska Z.
    Acta Haematol Pol; 1995; 26(4):413-20. PubMed ID: 8571743
    [Abstract] [Full Text] [Related]

  • 3. Combined use of reverse transcriptase polymerase chain reaction and flow cytometry to study minimal residual disease in Philadelphia positive acute lymphoblastic leukemia.
    Muñoz L, López O, Martino R, Brunet S, Bellido M, Rubiol E, Sierra J, Nomdedéu JF.
    Haematologica; 2000 Jul; 85(7):704-10. PubMed ID: 10897122
    [Abstract] [Full Text] [Related]

  • 4. Overexpression of CD49f in precursor B-cell acute lymphoblastic leukemia: potential usefulness in minimal residual disease detection.
    DiGiuseppe JA, Fuller SG, Borowitz MJ.
    Cytometry B Clin Cytom; 2009 Mar; 76(2):150-5. PubMed ID: 18831072
    [Abstract] [Full Text] [Related]

  • 5. [Detection of minimal residual disease in B lineage acute lymphoblastic leukemia by 4-color flow cytometry].
    Liu YR, Wang H, Chang Y, Cheng YF, Fu JY, Zhang LP, Liu GL, Chen SS.
    Zhonghua Xue Ye Xue Za Zhi; 2005 Jun; 26(6):327-31. PubMed ID: 16185473
    [Abstract] [Full Text] [Related]

  • 6. Expression of CD58 in normal, regenerating and leukemic bone marrow B cells: implications for the detection of minimal residual disease in acute lymphocytic leukemia.
    Veltroni M, De Zen L, Sanzari MC, Maglia O, Dworzak MN, Ratei R, Biondi A, Basso G, Gaipa G, I-BFM-ALL-FCM-MRD-Study Group.
    Haematologica; 2003 Nov; 88(11):1245-52. PubMed ID: 14607753
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Expression of CD10, CD19 and CD34 markers in bone marrow samples of children with precursor B-cell acute lymphoblastic leukemia in clinical and hematological remission.
    Cáp J, Babusíková O, Kaiserová E, Jamárik M.
    Neoplasma; 1998 Nov; 45(4):231-6. PubMed ID: 9890666
    [Abstract] [Full Text] [Related]

  • 11. Increased myeloid precursors in regenerating bone marrow; implications for detection of minimal residual disease in acute myeloid leukemia.
    Zeleznikova T, Stevulova L, Kovarikova A, Babusikova O.
    Neoplasma; 2007 Nov; 54(6):471-7. PubMed ID: 17949229
    [Abstract] [Full Text] [Related]

  • 12. [Detection of minimal residual disease in patients with acute myeloid leukemia].
    Gal'tseva IV, Savchenko VG, Kulikov SM, Parovichnikova EN, Miterev GIu, Maslova ER, Isaev VG.
    Ter Arkh; 2003 Nov; 75(7):8-14. PubMed ID: 12934474
    [Abstract] [Full Text] [Related]

  • 13. Minimal residual disease monitoring in adult T-cell acute lymphoblastic leukemia: a molecular based approach using T-cell receptor G and D gene rearrangements.
    Gameiro P, Mortuza FY, Hoffbrand AV, Foroni L.
    Haematologica; 2002 Nov; 87(11):1126-34. PubMed ID: 12414341
    [Abstract] [Full Text] [Related]

  • 14. Flow cytometric determination of leukemia-associated marker combinations for the study of minimal residual disease.
    Babusíková O, Glasová M, Kusenda J, Koníková E, Mésárosová A.
    Neoplasma; 1994 Nov; 41(6):305-13. PubMed ID: 7870213
    [Abstract] [Full Text] [Related]

  • 15. The impact of cell heterogeneity and immunophenotypic changes on monitoring minimal residual disease in acute myeloid leukemia.
    Zelezníková T, Babusíková O.
    Neoplasma; 2006 Nov; 53(6):500-6. PubMed ID: 17167719
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Incidence, sensitivity, and specificity of leukemia-associated phenotypes in acute myeloid leukemia using specific five-color multiparameter flow cytometry.
    Al-Mawali A, Gillis D, Hissaria P, Lewis I.
    Am J Clin Pathol; 2008 Jun; 129(6):934-45. PubMed ID: 18480011
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.